journal
https://read.qxmd.com/read/39283944/an-update-on-highly-pathogenic-avian-influenza-a-h5n1-virus-clade-2-3-4-4b
#1
JOURNAL ARTICLE
Richard J Webby, Timothy M Uyeki
Since the resurgence of highly pathogenic avian influenza (HPAI) A(H5N1) virus, clade 2.3.4.4b, during 2021, these viruses have spread widely among birds worldwide, causing poultry outbreaks and infections of a wide range of terrestrial and marine mammal species. During 2024, HPAI A(H5N1) virus, clade 2.3.4.4b, was detected in dairy cattle for the first time and caused an ongoing multistate outbreak, with high levels of virus documented in raw cow milk. Human infections with clade 2.3.4.4b viruses from exposures to infected poultry or dairy cattle have resulted in a wide spectrum of illness severity, from conjunctivitis or mild respiratory illness to severe and fatal pneumonia in different countries...
September 16, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39283939/personal-protective-equipment-guidance-for-highly-pathogenic-avian-influenza-h5n1-should-be-adapted-to-meet-the-needs-of-dairy-farm-workers
#2
JOURNAL ARTICLE
Natasha Bagdasarian, Nora Wineland, Sarah Lyon Callo
No abstract text is available yet for this article.
September 16, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39279435/immunogenicity-and-reactogenicity-of-high-dose-or-standard-dose-influenza-vaccine-in-a-second-consecutive-influenza-season
#3
JOURNAL ARTICLE
Hannah Bahakel, Andrew J Spieker, Haya Hayek, Jennifer E Schuster, Lubna Hamdan, Daniel E Dulek, Carrie L Kitko, Tess Stopczynski, Einas Batarseh, Zaid Haddadin, Laura S Stewart, Anna Stahl, Molly Potter, Herdi Rahman, Justin Amarin, Spyros A Kalams, Claire E Bocchini, Elizabeth A Moulton, Susan E Coffin, Monica I Ardura, Rachel L Wattier, Gabriela Maron, Michael Grimley, Grant Paulsen, Christopher J Harrison, Jason Freedman, Paul A Carpenter, Janet A Englund, Flor M Munoz, Lara Danziger-Isakov, Natasha Halasa
BACKGROUND: Pediatric hematopoietic cell transplant (HCT) recipients are at high-risk for morbidity from influenza virus infection. We demonstrated in a primary phase II randomized controlled trial that two post-HCT doses of high-dose trivalent influenza vaccine (HD-TIV) given four weeks apart were more immunogenic than two doses of standard-dose quadrivalent influenza vaccine (SD-QIV). Herein, we present immunogenicity and safety of influenza vaccination in a consecutive season post-HCT using the same dosing regimen...
September 16, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39271142/changes-in-genital-hpv-prevalence-during-12-years-girls-only-bivalent-hpv-vaccination-results-from-a-biennial-repeated-cross-sectional-study
#4
JOURNAL ARTICLE
Johannes M A Kusters, Maarten F Schim van der Loeff, Janneke C M Heijne, Audrey J King, Hester E de Melker, Titia Heijman, Johannes A Bogaards, Birgit H B van Benthem
BACKGROUND: From 2009 until 2021, bivalent HPV vaccination was offered only to girls in the Netherlands. We aimed to study the impact of girls-only HPV vaccination on genital HPV prevalence among young adults. METHODS AND FINDINGS: PASSYON is a biennial repeated cross-sectional study (2009-21) among sexual health clinic clients aged 16-24 years old. Questionnaires elicited data on demographics, sexual behaviour and HPV vaccination status. Genital samples were collected and analysed using a PCR-based assay (SPF10-LiPA25)...
September 13, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39269503/early-robust-mucosal-secretory-iga-but-not-igg-response-to-sars-cov-2-spike-in-oral-fluid-is-associated-with-faster-viral-clearance-and-covid-19-symptom-resolution
#5
JOURNAL ARTICLE
Nora Pisanic, Annukka A R Antar, Marissa K Hetrich, Zoe O Demko, Xueyan Zhang, Kristoffer Spicer, Kate L Kruczynski, Barbara Detrick, William Clarke, Maria Deloria Knoll, David L Thomas, Fatimah S Dawood, Vic Veguilla, Ruth A Karron, Yukari C Manabe, Christopher D Heaney
BACKGROUND: High priority efforts are underway to support the development of novel mucosal COVID-19 vaccines, such as the US Government's Project NextGen and the Center for Epidemic Preparedness Innovations' goal to respond to the next pandemic with a new vaccine in 100 days. However, there is limited consensus about the complementary role of mucosal immunity in disease progression and how to evaluate immunogenicity of mucosal vaccines. This study investigated the role of oral mucosal antibody responses in viral clearance and COVID-19 symptom duration...
September 12, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39269490/evaluation-of-the-feasibility-and-efficacy-of-point-of-care-antibody-tests-for-biomarker-guided-management-of-covid-19
#6
JOURNAL ARTICLE
Cavan Reilly, Eleftherios Mylonakis, Robin Dewar, Barnaby Young, Jacqueline Nordwall, Sanjay Bhagani, Po-Ying Chia, Ruby Davis, Clark Files, Adit A Ginde, Timothy Hatlen, Marie Helleberg, Awori Hayanga, Tomas O Jensen, Mamta K Jain, Ioannis Kalomenidis, Kami Kim, Perrine Lallemand, Birgitte Lindegaard, Anupama Menon, Katherine Ognenovska, Garyfallia Poulakou, Birgit Thorup Røge, Angela J Rogers, Katy Shaw-Saliba, Uriel Sandkovsky, Barbara W Trautner, Shikha S Vasudeva, Andrew Vekstein, Kimberley Viens, James Wyncoll, Brian DuChateau, Zhenxing Zhang, Shujiang Wu, Abdel G Babiker, Victoria Davey, Annetine Gelijns, Elizabeth Higgs, Virginia Kan, Jens Lundgren, Gail V Matthews, H Cliff Lane
BACKGROUND: Biomarker guided therapy could improve management of COVID-19 inpatients. Although some results indicate that antibody tests are prognostic, little is known about patient management using point-of-care (POC) antibody tests. METHODS: COVID-19 inpatients were recruited to evaluate 2 POC tests: LumiraDX and RightSign. Ease of use data was collected. Blood was also collected for centralized testing using established antibody assays (GenScript cPass). A nested case-control study assessed if POC tests conducted on stored specimens were predictive of time to sustained recovery, mortality, and a composite safety outcome...
September 12, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39259351/increased-proportions-of-invasive-pneumococcal-disease-cases-amongs-adults-experiencing-homelessness-sets-stage-for-new-serotype-4-capsular-switch-recombinant
#7
JOURNAL ARTICLE
Bernard Beall, Sopio Chochua, Ben Metcalf, Wuling Lin, Theresa Tran, Zhongya Li, Yuan Li, Meghan L Bentz, Mili Sheth, Gunars Osis, Lesley McGee
BACKGROUND: The Centers for Disease Control and Prevention's Active Bacterial Core surveillance (ABCs) identified increased serotype 4 invasive pneumococcal disease (IPD), particularly among adults experiencing homelessness (AEH). METHODS: We quantified IPD cases during 2016-2022. Employing genomic-based characterization of IPD isolates, we identified serotype-switch variants. Recombinational analyses were used to identify the genetic donor and recipient strains that generated a serotype 4 progeny strain...
September 11, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39255068/retrospective-analysis-of-blood-biomarkers-of-neurological-injury-in-human-cases-of-viral-infection-and-bacterial-sepsis
#8
JOURNAL ARTICLE
Maggie L Bartlett, Heather Goux, Linwood Johnson, Kevin L Schully, Melissa Gregory, Joost Brandsma, Josh G Chenoweth, Danielle V Clark, Luis Felipe Rivera, Carlos Lezcano-Coba, Amy Y Vittor, Ronald Hayes, Josefrancisco Galué, Jean-Paul Carrera, Darci R Smith
BACKGROUND: Blood biomarkers of neurological injury could provide a rapid diagnosis of central nervous system (CNS) injury caused by infections. An FDA-approved assay for mild traumatic brain injury (TBI) measures glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), which signal astrocyte and neuronal injury, respectively. Here, we assessed the applicability of this biomarker assay for determining infection-induced brain injury. METHODS: We measured serum levels of GFAP and UCH-L1 retrospectively in serum samples from three study populations: 1) human cases infected with Venezuelan equine encephalitis virus (VEEV) and Madariaga virus (MADV) (n = 73), 2) human sepsis patients who were severely ill or diagnosed with encephalitis (n = 66), and 3) sepsis cases that were subsequently evaluated for cognitive impairment (n = 64)...
September 10, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39254040/economic-analyses-for-disease-surveillance-planning-and-advocacy
#9
JOURNAL ARTICLE
Lee M Hampton
Public health disease surveillance can guide a range of decisions related to the protection of populations. Economic analysis can be used to assess how surveillance for specific diseases can substitute for or complement other public health interventions and how to structure surveillance most efficiently. Assessing the value and costs of different disease surveillance options as part of broader disease prevention and control efforts is important for both using available resources efficiently to protect populations and communicating the need for additional resources as appropriate...
September 10, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39253950/covid-19-mrna-vaccines-induce-robust-levels-of-igg-but-limited-amounts-of-iga-within-the-oronasopharynx-of-young-children
#10
JOURNAL ARTICLE
Ying Tang, Brittany P Boribong, Zoe N Swank, Melina Demokritou, Maria A F Luban, Alessio Fasano, Michelle Du, Rebecca L Wolf, Joseph Griffiths, John Shultz, Ella Borberg, Sujata Chalise, Wanda I Gonzalez, David R Walt, Lael M Yonker, Bruce H Horwitz
BACKGROUND: Understanding antibody responses to SARS-CoV-2 vaccination is crucial for refining COVID-19 immunization strategies. Generation of mucosal immune responses, including mucosal IgA, could be of potential benefit to vaccine efficacy, yet limited evidence exists regarding the production of mucosal antibodies following the administration of current mRNA vaccines to young children. METHODS: We measured the levels of antibodies against SARS-CoV-2 from a cohort of children under 5 years of age (N=24) undergoing SARS-CoV-2 mRNA vaccination (serially collected, matched serum and saliva samples) or in a convenience sample of children under 5 years of age presenting to pediatric emergency department (nasal swabs, N=103)...
September 10, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39250760/role-of-hla-b-58-01-restricted-cd8-t-cells-in-hiv-1-subtype-ae-infection
#11
JOURNAL ARTICLE
Hung The Nguyen, Takayuki Chikata, Yu Zhang, Giang Van Tran, Hiroyuki Gatanaga, Shinichi Oka, Masafumi Takiguchi
HLA-B*58:01 and HLA-B*57 are protective alleles against HIV-1 subtype B or C infection whereas these HLA alleles have not been reported as protective in HIV-1 subtype AE infection. Although HLA-B*58:01-restricted and HLA-B*57-restricted HIV-1-specific CD8+ T cells have been thoroughly analyzed in subtype B or C infection, they have only been partially analyzed in subtype AE infection. We identified six HLA-B*58:01-restricted subtype AE epitopes in Vietnamese individuals infected with subtype AE. HLA-B*58:01-restricted T-cell responses to Gag epitopes, which may control disease progression in HLA-B*58:01+ and HLA-B*57+ individuals infected with subtype B or C, were not protective in subtype AE infection...
September 9, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39250505/chlamydia-trachomatis-induces-low-frequency-sustained-cd4-t-cell-responses-in-most-women-predominantly-targeting-chlamydial-protease-like-activity-factor-cpaf
#12
JOURNAL ARTICLE
Yanli Li, Joanna A Warren, Taylor B Poston, Genevieve Clutton, Fiona R Shaw, Shayla Z Conrad, Yinyan Xu, Xiaojing Zheng, Kacy S Yount, Catherine M O'Connell, Harold C Wiesenfeld, Toni Darville, Nilu Goonetilleke
BACKGROUND: Chlamydia trachomatis (CT) is a globally prevalent sexually transmitted infection (STI) that can result in pelvic inflammatory disease, ectopic pregnancy and infertility in women. Currently, there is no prophylactic vaccine. METHODS: This study examined T cell immunity in a cohort of women recently infected with CT. Participants were screened against peptides spanning 33 of 894 possible CT proteins, either ex vivo or using short-term cell lines (STCL)...
September 9, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39248523/a-longitudinal-analysis-of-memory-immune-responses-in-convalescent-crimean-congo-hemorrhagic-fever-survivors-in-uganda
#13
JOURNAL ARTICLE
Courtney A Cohen, Stephen Balinandi, Ana I Kuehne, Michelle L Rock, Luke G Bonagofski, Keersten M Ricks, Ian Davis, Dafna Abelson, Spencer W Stonier, Matthew Odongo, Zachary A Bornholdt, Larry Zeitlin, Crystal Moyer, Stephen Cose, John M Dye, Julius J Lutwama, Andrew S Herbert
Evaluating the adaptive immune responses to natural infection with Crimean-Congo hemorrhagic fever (CCHF) virus (CCHFV) in human survivors is critical to the development of medical countermeasures. However, the correlates of protection are unknown. As the most prevalent tick-borne human hemorrhagic fever virus with case fatality rates of 5%-30% and worldwide distribution, there is an urgent need to fill these knowledge gaps. Here, we describe adaptive immune responses in a cohort of Ugandan CCHF survivors via serial sampling over 6 years...
September 9, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39248500/vaginal-bacteria-and-proinflammatory-host-immune-mediators-as-biomarkers-of-human-immunodeficiency-virus-acquisition-risk-among-african-women
#14
JOURNAL ARTICLE
Sujatha Srinivasan, Barbra A Richardson, Jacqueline M Wallis, Tina L Fiedler, Susan M Strenk, Noah G Hoffman, Sean Proll, Z Mike Chirenje, Edward W Livant, David N Fredricks, Sharon L Hillier, Jeanne M Marrazzo
BACKGROUND: Few investigations have assessed contributions of both vaginal bacteria and proinflammatory immune mediators to human immunodeficiency virus (HIV) acquisition risk in a prospective cohort. METHODS: We conducted a nested case-control study of African women who participated in a randomized placebo-controlled trial of daily oral versus vaginal tenofovir-based preexposure prophylaxis for HIV infection. Vaginal concentrations of 23 bacterial taxa and 16 immune mediators were measured...
September 9, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39248312/shigella-and-etec-have-replaced-rotavirus-as-main-causes-of-childhood-diarrhea-in-rwanda-after-ten-years-of-rotavirus-vaccination
#15
JOURNAL ARTICLE
Jean Bosco Munyemana, Jean Claude Kabayiza, Staffan Nilsson, Maria E Andersson, Magnus Lindh
The causes of diarrhea after ten years of rotavirus vaccination in Rwanda were investigated in 496 children with and 298 without diarrhea using a real-time PCR. Rotavirus was detected in 11% of children with diarrhea (OR 2.48, P=0.002). Comparison of population attributable fractions (PAF) show that Shigella (PAF=11%) and ETEC-eltB (PAF=12%) have replaced rotavirus as the main causative agents. The PAF for rotavirus had declined from 41% pre-vaccination to 6.5%, indicating that rotavirus has become one among several similarly important causes of childhood diarrhea in Rwanda...
September 9, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39226296/in-depth-analysis-of-the-hiv-reservoir-confirms-effectiveness-and-safety-of-dtg-3tc-in-a-phase-4-randomized-controlled-switch-trial-rumba
#16
JOURNAL ARTICLE
Marie-Angélique De Scheerder, Sophie Degroote, Mareva Delporte, Maja Kiselinova, Wim Trypsteen, Lara Vincke, Evelien De Smet, Bram Van Den Eeckhout, Loïc Schrooyen, Maxime Verschoore, Camilla Muccini, Sophie Vanherrewege, Els Caluwe, Stefanie De Buyser, Sarah Gerlo, Evy Blomme, Linos Vandekerckhove
BACKGROUND: Reducing the number of active compounds for lifelong HIV treatment is of interest, especially to reduce potential long-term side effects. So far, available data assessing viral control, support the robustness and safety of 2DR (2-drug regimen) ART compared to 3DR. However, further in-depth investigations of the viral reservoirs are mandatory to guarantee long-term safety of these regimens regarding stable intact HIV-1 DNA copies, HIV-1 RNA transcripts and sustained immunological control...
September 3, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39225478/association-between-sars-cov-2-viral-load-and-covid-19-vaccination-in-4-phase-3-trials
#17
JOURNAL ARTICLE
Holly Janes, Leigh H Fisher, Jia Jin Kee, Lalitha Parameswaran, Paul A Goepfert, Ann R Falsey, James Ludwig, Craig A Magaret, Peter B Gilbert, James G Kublin, Nadine Rouphael, Magdalena E Sobieszczyk, Hana M El Sahly, Lindsey R Baden, Beatriz Grinsztejn, Stephen R Walsh, Glenda E Gray, Karen L Kotloff, Cynthia L Gay, Alexander L Greninger, Milagritos D Tapia, E Adrianne Hammershaimb, Frances H Priddy, Justin A Green, Frank Struyf, Lisa Dunkle, Kathleen M Neuzil, Lawrence Corey, Yunda Huang
Coronavirus disease 2019 (COVID-19) vaccines reduce severe disease and mortality and may lessen transmission, measured by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL). Evaluating vaccine associations in VL at COVID-19 diagnosis in 4 phase 3 randomized, placebo-controlled vaccine trials, July 2020 to July 2021, VL reductions were 2.78 log10 copies/mL (95% confidence interval [CI], 1.38-4.18; n = 60 placebo, 11 vaccine) and 2.12 log10 copies/mL (95% CI, 1.44-2.80; n = 594 placebo, 36 vaccine) for NVX-CoV2373 and mRNA-1273, respectively...
September 3, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39219411/elevated-plasma-matrix-metalloproteinases-are-associated-with-mycobacterium-tuberculosis-bloodstream-infection-and-mortality-in-human-immunodeficiency-virus-associated-tuberculosis
#18
JOURNAL ARTICLE
Naomi F Walker, Charlotte Schutz, Amy Ward, David Barr, Charles Opondo, Muki Shey, Paul T Elkington, Katalin A Wilkinson, Robert J Wilkinson, Graeme Meintjes
Mortality from human immunodeficiency virus (HIV)-associated tuberculosis (TB) is high, particularly among hospitalized patients. In 433 people with HIV hospitalized with symptoms of TB, we investigated plasma matrix metalloproteinases (MMP) and matrix-derived biomarkers in relation to TB diagnosis, mortality, and Mycobacterium tuberculosis (Mtb) bloodstream infection (BSI). Compared to other diagnoses, MMP-8 was elevated in confirmed TB and in Mtb-BSI, positively correlating with extracellular matrix breakdown products...
September 2, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39215587/clinical-application-of-phage-immunoprecipitation-sequencing-to-diagnose-enterovirus-d68-as-the-underlying-etiology-in-a-case-of-gullain-barr%C3%A3-syndrome
#19
JOURNAL ARTICLE
Fang Fang Li, Alison Faber, Jessica M Caleta, David M Goldfarb, Inna Sekirov, Natalie A Prystajecky, Jocelyn A Srigley, Ram Mishaal, Agatha N Jassem
Gullain-Barré syndrome (GBS) is an acute peripheral neuropathy often preceded by respiratory or gastrointestinal infections, though molecular testing of cerebrospinal fluid (CSF) is often inconclusive. In a recent case of severe pediatric GBS in British Columbia, Canada, we detected CSF antibodies against enterovirus D (EV-D) to link GBS with prior EV-D68 respiratory infection.
August 31, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/39213381/molecular-epidemiology-of-wild-poliovirus-type-1-and-shift-in-the-historically-reservoir-areas-of-pakistan-during-2019-2022
#20
JOURNAL ARTICLE
Yasir Arshad, Nayab Mehmood, Muhammad Masroor Alam, Adnan Khurshid, Ribqa Akhtar, Ghulam Mujtaba, Lubna Rehman, Nighat Mushtaq, Bisma Sarfraz, Rabia Hakim, Massab Umair, Muhammad Suleman Rana, Muhammad Salman, Salmaan Sharif, Sadia Sattar, Sundus Javed, Muzzamil Ahmed, Zainul Abedin Khan, Mohammed Ahmed Soghaier, Nazish Bostan
BACKGROUND: Pakistan is one of the two countries endemic for wild poliovirus type 1 (WPV1). Active clinical and environmental wastewater surveillance along with laboratory investigation is an integral and primary component of the polio eradication strategies. The current study is mainly focused on the virological data to understand the current epidemiology of WPV1 in Pakistan during 2019-2022. METHODS: 141,037 stool specimens of patients reported with acute flaccid paralysis (AFP) and 3,171 wastewater samples were tested for poliovirus detection using cell culture and PCR...
August 30, 2024: Journal of Infectious Diseases
journal
journal
20154
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.